Characterization of high level ampicillin- and aminoglycoside-resistant enterococci isolated from non-hospital sources. 2017

Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
Department of Veterinary Microbiology, Ahmadu Bello University, Zaria, Kaduna State, Nigeria.

OBJECTIVE High level ampicillin- and aminoglycoside-resistant enterococci are being increasingly reported from non-hospital sources. This study was carried out to characterize these strains from non-hospital sources in Nigeria. METHODS A collection of Enterococcus faecium isolated from vegetables, soil, farm animals and manure and observed to be resistant to ampicillin (n=63) and gentamicin (n=37) discs, were screened for resistance to high levels of ampicillin and aminoglycoside using E-test strips. Putative high level ampicillin- and aminoglycoside-resistant strains were screened for pbp5 and aminoglycoside modifying enzyme genes, respectively, by PCR. The C-terminal region of the amplified pbp5 gene was also sequenced. RESULTS Five (5/63) and thirty-five (35/37) of the ampicillin- and aminoglycoside-resistant strains were identified as high level ampicillin- and aminoglycoside-resistant E. faecium strains, respectively, based on the MIC results. The amplified pbp5 gene from the high level ampicillin-resistant isolates displayed 96-99 % nucleotide sequence similarity with the reference strains and three novel insertions (500Glu→Leu, 502Asp→Arg and 614Ile→Phe) in the amino acid sequence. Aminoglycoside modifying enzyme genes aac(6')-Ie-aph(2″) (100 %), aph(2')-Ic (88.8 %), aph(3')-IIIa (90 %) and ant(4')-Ia (40 %) were detected among the high level aminoglycoside-resistant isolates. CONCLUSIONS This is the first report on the characterization of high level ampicillin- and aminoglycoside-resistant Enterococcus faecium among animals and vegetables in Nigeria. The results show that non-hospital sources can constitute a reservoir for potential dissemination of these strains and genes to humans via the food chain or by direct contact.

UI MeSH Term Description Entries
D009549 Nigeria A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja. Federal Republic of Nigeria
D004783 Environmental Microbiology The study of microorganisms living in a variety of environments (air, soil, water, etc.) and their pathogenic relationship to other organisms including man. Microbiology, Environmental
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016908 Gram-Positive Bacterial Infections Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. Bacterial Infections, Gram-Positive,Infections, Gram-Positive Bacterial,Bacterial Infection, Gram-Positive,Bacterial Infections, Gram Positive,Gram Positive Bacterial Infections,Gram-Positive Bacterial Infection,Infection, Gram-Positive Bacterial,Infections, Gram Positive Bacterial
D016984 Enterococcus faecium A species of gram-positive, coccoid bacteria whose organisms are normal flora of the intestinal tract. Unlike ENTEROCOCCUS FAECALIS, this species may produce an alpha-hemolytic reaction on blood agar and is unable to utilize pyruvic acid as an energy source. Streptococcus faecium

Related Publications

Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
April 2005, Epidemiology and infection,
Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
July 1988, Journal of clinical microbiology,
Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
January 2004, Avian diseases,
Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
January 2004, Microbial drug resistance (Larchmont, N.Y.),
Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
March 2000, The Journal of antimicrobial chemotherapy,
Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
November 2005, The Journal of antimicrobial chemotherapy,
Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
June 1992, The Journal of antimicrobial chemotherapy,
Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
May 1997, The Indian journal of medical research,
Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
September 1987, Archives of internal medicine,
Emmanuel O Ngbede, and Mashood A Raji, and Clara N Kwanashie, and Jacob K P Kwaga, and Alex A Adikwu, and Nanven A Maurice, and Andrew M Adamu
December 2018, Germs,
Copied contents to your clipboard!